Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xbiotech Inc (NQ: XBIT ) 6.440 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 6.440 Bid (Size) 4.000 (86) Ask (Size) 9.000 (5) Prev. Close 6.440 Today's Range 6.440 - 6.440 52wk Range 3.510 - 9.960 Shares Outstanding 30,436,964 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 August 12, 2024 XBiotech just reported results for the second quarter of 2024. Via InvestorPlace What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? June 18, 2024 XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin... Via Benzinga Performance YTD +48.39% +48.39% 1 Month +3.70% +3.70% 3 Month -24.59% -24.59% 6 Month +6.27% +6.27% 1 Year +25.05% +25.05% More News Read More XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer June 18, 2024 From XBiotech Inc. Via GlobeNewswire XBIT Stock Earnings: XBiotech Reported Results for Q1 2024 May 13, 2024 Via InvestorPlace XBIT Stock Earnings: XBiotech Reported Results for Q4 2023 March 18, 2024 Via InvestorPlace Stocks That Hit 52-Week Lows On Thursday October 20, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 22, 2024 Via Benzinga XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus January 04, 2024 From XBiotech Inc. Via GlobeNewswire Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis November 14, 2023 From XBiotech Inc. Via GlobeNewswire XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke September 26, 2023 From XBiotech Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session September 05, 2023 Via Benzinga XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled, Multicenter Study for Natrunix in Pancreatic Cancer August 30, 2023 From XBiotech Inc. Via GlobeNewswire XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial August 08, 2023 From XBiotech Inc. Via GlobeNewswire FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients May 22, 2023 From XBiotech Inc. Via GlobeNewswire Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 17, 2023 Via Benzinga Dow Jumps Over 100 Points; US Housing Starts Rise In April May 17, 2023 Via Benzinga XBiotech Commences Tender Offer to Purchase up to $80,000,000 Worth of Its Shares May 17, 2023 From XBiotech Inc. Via GlobeNewswire XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke April 17, 2023 From XBiotech Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Monday November 28, 2022 Via Benzinga XBiotech Announces First Patient Enrolled into the French National Cancer Institute (INCA) Sponsored Phase I/II/III Clinical Study for Natrunix™ Therapy for Colorectal Cancer October 13, 2022 From XBiotech Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Monday August 22, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 22, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 20, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Monday September 19, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday August 31, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
